about
The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophreniaInvited review: the evolution of antidepressant mechanismsAntidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.Basic mechanisms of psychotropic drugs.Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss miceEffects of stimulation and blockade of d(2) receptor on depression-like behavior in ovariectomized female rats.Serotonin transporters: implications for antidepressant drug development.The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.Combination of valproate and paroxetine in mice exposed to picrotoxinTransgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test.The effect of sympathetic antagonists on the antidepressant action of alprazolam.Effects of calcium channel blockers on antidepressant action of Alprazolam and Imipramine.Benzo[α]pyrene-induced anti-depressive-like behaviour in adult female mice: role of monoaminergic systems.Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II.Rats subjected to extended L-tryptophan restriction during early postnatal stage exhibit anxious-depressive features and structural changes.Effect of antidepressant drugs in mice lacking the norepinephrine transporter.Structural basis for recognition of diverse antidepressants by the human serotonin transporter.Stress-induced changes in social dominance are scaled by AMPA-type glutamate receptor phosphorylation in the medial prefrontal cortex
P2860
Q28210979-A9DFA502-29EB-4885-B1CD-E86E84EBAE1CQ28241221-A5335D44-ECF3-40EB-97AC-8FD023C29922Q33671819-BD01A835-3606-4223-99DC-EED7807B8690Q34521815-96D4D15E-611C-4B0A-AA1C-633F907691BAQ35045542-F2B71A31-6E9D-48EA-841B-1C2AE4A6A08FQ35045894-FA3110C6-E620-4450-91AA-513229BF4194Q35864182-9943DCC6-2E48-4571-94B4-560C009E9817Q36341615-F871F59E-38B5-4F5D-A3ED-E70E7B1E8FA0Q37278592-44DCD9A5-93E9-41FF-A989-1A3D3759CAADQ39447754-4FDB1809-C186-4A10-9CFF-08618D4DB3DAQ41665042-407B961A-6C36-428C-8D36-1885CB1B2534Q41971748-6C170F1B-723D-4381-AD5C-7758E7C3EFF7Q42677754-C202FAFB-57E1-4C07-BD77-744362F54BECQ42714411-C8714D0E-FBF1-4C88-8511-7823F8BEBC50Q42718134-776C91B7-E7AD-41DC-A03A-8B55E136A9CFQ42722622-5E572F43-F402-42A2-86F9-156F21D92B6EQ42920341-97B08BD7-9020-477A-8053-EBA3551901D4Q48493682-8A44D16E-0384-4E3C-B952-F97D5990AB7FQ48607788-9F755A48-9308-471A-94FB-291CF40AD99AQ49594975-9BB09A3B-F258-49A6-B704-E620FF339E40Q57292415-4DE3D28D-68E2-4CC2-8F58-B3AE85EB2ECB
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antidepressants: past, present and future.
@ast
Antidepressants: past, present and future.
@en
Antidepressants: past, present and future.
@nl
type
label
Antidepressants: past, present and future.
@ast
Antidepressants: past, present and future.
@en
Antidepressants: past, present and future.
@nl
prefLabel
Antidepressants: past, present and future.
@ast
Antidepressants: past, present and future.
@en
Antidepressants: past, present and future.
@nl
P1476
Antidepressants: past, present and future.
@en
P2093
Vetulani J
P304
P356
10.1016/S0014-2999(00)00565-3
P407
P50
P577
2000-09-01T00:00:00Z